Skip to main content

Select Drug Profiles

Monoclonal Antibody Produces Powerful Reductions in LDL Cholesterol

Boosting HDL Provides No Additional Benefit in Patients Already Taking a Statin

Low-Potency Statins Initiated in High-Risk Patients in a Managed Care Setting

New Drug Therapies for Difficult-to-Control Atrial Fibrillation

Cardiac Resynchronization Therapy Still Challenging in Patients with Atrial Fibrillation and Heart Failure

Dabigatran Safe and Effective Anticoagulant Postablation in Patients with Atrial Fibrillation

Blood Assay for Galectin-3 Identifies Heart Failure Risk of Patients in the Community Setting

Advances in Stem-Cell Therapy for Heart Failure

Comparative Effectiveness Analysis of Antithrombotics in Older Patients with Post-ACS Atrial Fibrillation

Comparative Effectiveness Analysis: Emergency Department CTA versus Standard ACS Symptom Evaluation

Page 203 of 244
Results 2021 - 2030 of 2438